Firebrick Pharma LimitedASX: FRE

Firebrick Secures $732k in Strategic Investments

· Issued by Firebrick Pharma Limited via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

The investment includes significant contributions from its licensing partner in the Philippines, Pharma Nutria N.A. Inc., and an existing investor. Proceeds from the placement will be used for new production for US retail distribution, launching a new product in Singapore, and working capital.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Firebrick Pharma Ltd | ABN 64 157 765 896 | L14, 333 Collins St. Melbourne, VIC, 3000, Australia P: 1300 301 874 | W: firebrickpharma.com 12 October 2026 ASX Announcement Firebrick Secures $732k in Strategic Investments Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) is pleased to...

Firebrick Pharma Limited on 6ix

Earlier from Firebrick Pharma

Later from Firebrick Pharma

All Firebrick Pharma news releases